- Parties: The plaintiffs were Novartis Pharmaceuticals Canada Inc. and Novartis AG. The defendant was Apotex Inc.

- Subject Matter: This action was filed under the Patented Medicines (Notice of Compliance) Regulations to prevent Apotex from launching a generic version of a drug allegedly protected by Novartis’s patents. This case is ongoing.

- Date: The hearing was set on August 21, 2025.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.